Alcoa Inc (NYSE:AA)
On Friday, Alcoa Inc (NYSE:AA)’s shares inclined 2.24% to $7.99.
AA has the market capitalization of $10.47 billion. The stock has P/B ratio of 0.82 while EPS was $0.39. Institutional ownership of the company was 61.30% while 1.31 billion shares were outstanding. Net profit margin of the Company was 2.00% while its gross profit margin was 21.20%. Share of the company moved below its SMA 50 with -15.35%. ROE ratio was 3.80% while ROI was 3.30%.
The mean estimate for the short term price target for Alcoa Inc (NYSE:AA) stands at $11.85 according to 13 Analysts. The higher price target estimate for the stock has been calculated at $15.00 while the lower price target estimate is at $8.00.
Analysts mean recommendation for the stock is 2.30. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Alcoa Inc. (Alcoa) is engaged in lightweight metals engineering and manufacturing. The Company operates in four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions.
SandRidge Energy Inc. (NYSE:SD)
SandRidge Energy Inc. (NYSE:SD)’s shares gained 9.71% to $0.390.
SD Its past 5-day performance at -7.03%. So far in 2015, the company has a year-to-date performance of -78.57%. The stock, as of last close, traded 56.00% up from its 52 week low and was -90.71% below its 52 week high. Its latest closing price was -63.78% below the SMA200 while the distance from SMA 50 and SMA 20 was -1.94% and 3.37% respectively.
The mean estimate for the short term price target for SandRidge Energy Inc. (NYSE:SD) stands at $0.61 according to 14 Analysts. The higher price target estimate for the stock has been calculated at $1.40.
Analysts mean recommendation for the stock is -3.40. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
SandRidge Energy, Inc. is an oil and natural gas company. The Company operates in three business segments: exploration and production, drilling and oil field services, and midstream services.
Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN)
At the end of Friday’s trade, Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN)‘s shares surged 6.06% to $1.40.
AXN has market capitalization of $104.02 million. Its current ratio was 0.50 while its shares were below its 50 days simple moving average with -5.63%. The company offered earning per share of $0.08 while its 74.30 million shares were outstanding. YTD performance of the company was 340.81%. Stock volatility for the week was 10.39% while for the month it was shown at 6.98%.
The mean estimate for the short term price target for Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) stands at $4.00 according to 1 Analysts. The higher price target estimate for the stock has been calculated at $4.00 while the lower price target estimate is at $4.00.
Analysts mean recommendation for the stock is 1.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical company, which specializes in research, development, manufacturing and distribution of a range of narcotics and pain-management products and drug-relief medicine.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.